1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:CT parameters in 29 patients with PPH stratified by outcome
CT Parameter Severe Disability, GOS Score < 4 (n = 17) Mild Disability Good Recovery, GOS Score ≥ 4 (n = 12) P Value* Death (n = 9) Survivors (n = 20) P Value* Mean hematoma volume (mL) 6.6 ± 2.7 2.8 ± 1.6 7.9 ± 2.6 3.7 ± 2.1 Hematoma ≥ 4 mL 14 (82) 3 (25) .006 9 (100) 8 (40) .003 Hematoma < 4 mL 3 (17) 9 (75) .006 0 12 (60) .003 Hematoma location Dorsal 0 9 (75) <.001 0 9 (45) .011 Ventral 12 (70) 3 (25) <.001 4 (44) 9 (45) .23 Massive 5 (29) 0 .002 5 (55) 0 <.001 Intraventricular hematoma extension 6 (35) 1 (8) .18 5 (55) 2 (10) .01 Hydrocephalus 7 (41) 2 (16) .23 6 (66) 3 (15) .01
Note.—Except for mean hematoma volume, data are number (%) of patients.
* Two-tailed Fisher exact test.